Market Cap : 30.38 B | Enterprise Value : 31.67 B | PE Ratio : 42.03 | PB Ratio : 2.77 |
---|
NAS:ILMN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:ILMN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.
Illumina's Capital Expenditure for the three months ended in Mar. 2022 was $-61.00 Mil. Its Operating Income for the three months ended in Mar. 2022 was $184.00 Mil.
Hence, Illumina's Capex-to-Operating-Income for the three months ended in Mar. 2022 was 0.33.
The historical data trend for Illumina's Capex-to-Operating-Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Illumina's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's Capex-to-Operating-Income distribution charts can be found below:
* The bar in red indicates where Illumina's Capex-to-Operating-Income falls into.
Illumina's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2021 is calculated as
Capex-to-Operating-Income | = | - Capital Expenditure | / | Operating Income |
= | - (-208) | / | -123 | |
= | N/A |
Illumina's Capex-to-Operating-Income for the quarter that ended in Mar. 2022 is calculated as
Capex-to-Operating-Income | = | - Capital Expenditure | / | Operating Income |
= | - (-61) | / | 184 | |
= | 0.33 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.
Thank you for viewing the detailed overview of Illumina's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Flatley Jay T | director | 9885 TOWNE CENTRE DR SAN DIEGO CA 92121 |
Tousi Susan H | officer: SVP Product Development | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Reeves Kathryne Gambrell | officer: SVP, Chief Marketing Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Goswami Joydeep | officer: SVP Corp Business Development | SUMITOMO FUDOSAN MITA TWIN BLDG EAST WING 4-2-8 SHIBAURA MINATO-KU TOKYO M0 1080023 |
Dadswell Charles | officer: SVP & General Counsel | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Desouza Francis A | director, officer: President and CEO | 350 ELLIS STREET MOUNTAIN VIEW CA 94043 |
Van Oene Mark | officer: SVP Chief Commercial Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Ragusa Robert P | officer: SVP, Global Quality & Ops | PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: RAGUSA ROBERT P a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;} |
Mcginnis Karen K | officer: VP, Chief Accounting Officer | INSIGHT ENTERPRISES INC 1305 WEST AUTO DRIVE TEMPE AZ 85284 |
Hoyt Aimee L | officer: SVP, Chief People Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Ronaghi Mostafa | officer: SVP, Entrepreneurial Devlopmt | 9885 TOWNE CENTRE DRIVE SAN DIEGO CA 92121 |
Aravanis Alexander | officer: SVP, Chief Technology Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Siegel Susan E | director | 3000 SAND HILL ROAD BLDG 3 STE 290 MENLO PARK CA 94025 |
Thompson John Wendell | director | C/O MICROSOFT CORPORATION ONE MICROSOFT WAY REDMOND WA 98053 |
Epstein Robert S | director | PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: EPSTEIN ROBERT S a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;} |
From GuruFocus
By PRNewswire 12-23-2021
Other Sources
By Zacks 2022-01-11
By Zacks 2022-02-09
By Seekingalpha 2022-03-07
By Zacks 2022-01-14
By Zacks 2022-02-18
By Zacks 2021-12-15
By Fool 2022-01-11
By Zacks 2022-01-12
By Zacks 2022-02-10
By Seekingalpha 2022-02-10
By Fool 2022-01-23
By Zacks 2022-02-10
By Fool 2022-01-11
By tipranks.com 2022-03-30